Nova Eye Medical Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ELXMF research report →
About the company
Headquartered in Kent Town, Australia, and established in 1985, Nova Eye Medical Limited is dedicated to the development, manufacturing, and global commercialization of surgical solutions for eye conditions, with a primary focus on glaucoma. Their product lineup features the iTrack surgical system, engineered to reduce intraocular pressure in adult patients with open-angle glaucoma, alongside its evolution, iTrack Advance, which promotes natural ocular fluid drainage. For individuals with severe or intricate forms of glaucoma, they provide the Molteno3 drainage device.
- CEO
- Victor Previn
- IPO
- 2010
- Employees
- 301
- HQ
- Kent Town, SA, AU
Price Chart
- Market Cap
- $4.08M
- P/E
- -4.10
- P/S
- 0.90
- P/B
- 1.89
- EV/EBITDA
- -8.26
- Div Yield
- 0.00%
- Gross Margin
- 66.71%
- Op Margin
- -15.77%
- Net Margin
- -21.27%
- ROE
- -40.41%
- ROIC
- -27.99%
- Revenue
- $29.27M · 25.47%
- Net Income
- $-9,059,000 · -3.06%
- EPS
- $-0.04 · 15.08%
- Op Income
- $-4,504,000
- FCF YoY
- 22.37%
- 52W High
- $0.10
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.03
- Beta
- 0.93
- Avg Volume
- 80
Get TickerSpark's AI analysis on ELXMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ELXMF coverage
Recent articles, reports, and earnings notes.
No research on ELXMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ELXMF report →Similar companies
Peers in the same neighborhood.